Number of pages: 100 | Report Format: PDF | Published date: October 11, 2022
Historical Years – 2020 | Base Year – 2021 | Forecasted Years – 2022-2030
Report Attribute |
Details |
Market size value in 2021 |
US$ 7.9 billion |
Revenue forecast in 2030 |
US$ 30.51 billion |
CAGR |
16.2% |
Base year for estimation |
2021 |
Forecast period |
2022-2030 |
Segments covered |
product, application, technology, end user, and region |
Regional scope |
North America, Europe, Asia Pacific, and the Rest of the World (RoW) |
According to the deep-dive market assessment study by Growth Plus Reports, the global Cell Separation Technology market was valued at US$ 7.9 billion in 2021. The market is expected to witness a CAGR of 16.2% from 2022 to 2030.
Market Fundamentals
Cell separation, also called cell isolation, is the process of isolating or separating a specific cell population from a heterogeneous population of cells. Experiments on isolated cells minimize the interference from other cell types in the sample, thus providing specificity in the research. The cell separation can be performed on complex biological samples such as Peripheral blood mononuclear cells (PBMCs), Leukapheresis products, and Whole peripheral blood.
[897435]
Market Dynamics
The rising application of cell separation in biologics development, in-vitro diagnostics, conducting molecular and epigenetic analysis, therapeutic protein production, and other life sciences research is the key factor fueling the growth of the global cell separation market. The increasing prevalence of chronic diseases globally leads to the demand for cell separation techniques in diagnostics. Research is also a significant factor contributing to the growth of the global market. Moreover, there is a rise in the demand for precision medicines and specialty drugs. The incorporation of advanced technology by the top market players in research and development to develop new novel vaccines, therapies, and testing kits is also increasing the demand for cell separation technologies. The growing initiatives by the government to improve the biotechnology industry are also expected to boost the growth of the global cell separation technology market. However, the cost of the products related to cell separation is high as the research required for cell-based therapy is extensive and has stringent guidelines by the regulatory authorities. It is the major restricting factor of the global market. Moreover, the success rate of research related to cell-based research is meager, and there is a lack of skilled cell biology professionals, thus hindering the growth of the global market.
Market Ecosystem
The global cell separation technology market has been analyzed from five perspectives: product, application, technology, end user, and region.
Cell Separation Technology Market by Product
The global cell separation technology market is divided into instruments and consumables based on product type. The consumable segment will have the largest market share of the global cell separation technology market in 2021. The large share of the consumable segment can largely be attributed to the rise in the investment by the companies in the R&D of different products that require consumables regularly compared to the instruments that can be reused.
Cell Separation Technology Market by Application
[3242323]
Based on application, the global cell separation technology market is bifurcated into oncology research, stem cell research, microbiology research, immunobiology research, neuroscience research, and others. The oncology research segment will have a prominent global market share in 2021. The rising prevalence of cancer has significantly increased the research related to cancer. Moreover, the increasing research in biologics and cell-based therapy is also boosting segment growth. Additionally, governments are providing favorable policies and investments for the research and development of cancer products, thus fueling segment growth.
Cell Separation Technology Market by Technology
Based on technology, the global cell separation technology market is segmented into density gradient centrifugation, immuno-magnetic cell separation, fluorescence-activated cell sorting (FACS), microfluidic cell separation, immuno-density cell separation, and others. The fluorescence-activated cell sorting (FACS) dominates the global cell separation technology market, with the highest market share in 2021. Fluorescence-activated cell sorting (FACS) provides high purity of the cell for the given sample. It offers a high range of cell sorting capabilities. Moreover, FACS provides a high throughput, thus ensuring enough cell population, therefore, increasing the preference for FACS over other techniques.
Cell Separation Technology Market by End-user
Based on end-users, the global cell separation technology market is segmented into hospitals & diagnostic centers, biotech and pharmaceutical company, and research & academia. The biotech and pharmaceutical company will have the most significant global cell separation market share in 2021. The rise in the research and development related to cancer and cell-based therapies plays a pivotal role in segment growth. Moreover, the government is providing favorable policies, and the continuous launch of new products is also expected to boost the market growth.
Cell Separation Technology Market by Region
Based on region, the global cell separation technology market has been segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America dominated the global cell separation technology market in 2021, followed by Europe and the Asia Pacific. The region's large share can be attributed to the well-established biotech and pharmaceutical sector with a large number of research institutes. Moreover, the rise in the research in the field of cell therapy in the region with the adoption of advanced technology is increasing the demand for cell separation technology. The rising prevalence and incidence rate of chronic disease have increased the demand for cell separation for research and clinical applications.
Competitive Landscape
Some prominent players operating in the global cell separation technology market are:
Strategic Developments
Some of the prominent players operating in the global cell separation technology market are Thermo Fisher Scientific Inc., Terumo Corporation, Becton Dickinson and Company Limited, Merck KGaA, Beckman Coulter Inc., GE Healthcare, Bio-Rad Laboratories Inc., Roche Diagnostics (F. Hoffmann-La Roche AG), Alfa Laval, STEMCELL Technologies Inc., PerkinElmer Inc., Akadeum Life Sciences Inc., Miltenyl Biotech, Bio-Techne, and and Invent Biotechnologies, among others.
The rising prevalence of chronic diseases is significantly increasing the research on stem cell therapy and biologics; it is a major global trend.
The CAGR of the cell separation technology market during the forecasting period is at 16.2% from 2022 to 2030.
The global cell separation technology is valued at US$ 7.9 billion in 2021.
*Insights on financial performance is subject to availability of information in public domain